Released Feb 26, 2018, after the close
10-K filed Feb 26, 2018, 57 days after period end · 0001564590-18-003256
Q4 2017 · 10-K
Revenue$116.90M$116.90M +7.7% vs Q4 2016+11.1% vs Q3 2017
Net Income$1.57M$1.57M N/M vs Q4 2016−54.6% vs Q3 2017
EPS Diluted$0.08$0.08 N/M vs Q4 2016−57.9% vs Q3 2017
Gross Profit$93,334,000+9.5%
Operating Income$17,860,000+140.8%
Operating Cash Flowderived$29,847,000+44.3%
Free Cash Flowderived$26,623,000+54.9%
Margins · derived
Gross margin79.8%+1.3 pt vs Q4 2016
Operating margin15.3%+8.4 pt vs Q4 2016
Net margin1.3%+4.3 pt vs Q4 2016
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Revenue | $116.90M | $108.54M | $104.62M | $100.28M |
| Net Income | $1.57M | -$3.24M | $3.37M | -$5.80M |
| EPS Diluted | $0.08 | -$0.18 | $0.18 | -$0.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR